2018 Cochrane-REWARD prize
We are looking for those currently: entries for the 2018 Cochrane-REWARD prize are still open (until the 15th of May). http://www.cochrane.org/news/apply-cochrane-reward-prize-reducing-waste-research Nominations will be assessed against 4 criteria: (1) addresses at least one of the 5 stages of research waste (questions, design, conduct, publication, reporting) in the area of health; (2) pilot or more definitive data showing the initiative can lower waste; (3) The initiative can be scaled up; and (4) the estimated potential reduction in research waste that the initiative might achieve. The prize will be presented at the annual Cochrane Colloquium in Edinburgh (15-18 September).
Rigour mortis: how bad research is killing science
On 26th May 2014, Prof. Malcolm Macleod gave his inaugural lecture at the University of Edinburgh entitled “Rigour mortis: how bad research is killing science”.
Waste in medical academia must be addressed, Chalmers urges in The BMJ Awards acceptance speech
On 8th May 2014, Iain Chalmers, one of the authors of the Lancet series, was presented with the 2014 GSK Lifetime Achievement Award during the BMJ Awards ceremony in London. This award is given to a doctor who has made an outstanding contribution to improving health or healthcare in the UK. It highlights Chalmer’s lifetime commitment to perfect evidence based medicine and improve clinical practice. During his acceptance speech, he said that “medical academia is wasting ‘massive’ amounts of taxpayers’ money, and the public must put it under pressure to change”. He also commended GSK for being the first global company to sign up to the AllTrials campaign and praised the good “moral leadership” of the BMJ on this matter.
Iain Chalmers is a British health services researcher, a founder of the Cochrane Collaboration and coordinator of the James Lind initiative.
Videos from symposium on the Lancet series online
Interview with Paul Glasziou
Accompanying the 2014 series on research in The Lancet is an interview and podcast with Paul Glasziou, Professor of Evidence-Based Medicine at Bond University, Australia. He is a key figure behind The Lancet Series and lead author of one of the articles.
In the interview, Paul Glasziou comments on the background work that led to the series, the future of systematic reviews, and his interest in non-drug research, over-diagnosis and over-detection.
In the podcast he additionally talks about the AllTrials campaign and the importance to register and report all clinical trials.
(Photo © Paul Glasziou/Les Irwig)